BIMI Medical(BIMI)
Search documents
Delisting of Securities of BIMI International Medical Inc.; The Dixie Group, Inc.; Clover Leaf Capital Corp.; Focus Impact BH3 Acquisition Company; Forza X1, Inc.; Vertex Energy, Inc; Slam Corp.; and HHG Capital Corporation from The Nasdaq Stock Market
GlobeNewswire News Room· 2025-01-10 22:13
NEW YORK, Jan. 10, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of BIMI International Medical Inc. BIMI International Medical Inc.’s stock was suspended on August 22, 2024 and has not traded on Nasdaq since that time. Nasdaq also announced today that it will delist the Class A ordinary shares, unit, warrant of Slam Corp. Slam Corp.’s stock was suspended on August 27, 2024 and has not traded on Nasdaq since that time. Nasdaq also announced today that i ...
BIMI Medical(BIMI) - 2023 Q3 - Quarterly Report
2023-12-18 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of Each Class Trading Symbol(s) Name of Each Exchange on Which Registered Common Stock, $0.001 par value BIMI The NASDAQ Capital Market FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ________ ...
BIMI Medical(BIMI) - 2023 Q2 - Quarterly Report
2023-11-21 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission File Number: 000-50155 BIMI International Medical Inc. (Exact name of registrant as specified in its charter) | --- | --- | --- | |- ...
BIMI Medical(BIMI) - 2023 Q1 - Quarterly Report
2023-05-18 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission File Number: 000-50155 BIMI International Medical Inc. (Exact name of registrant as specified in its charter) Delaware 02-0563302 ( ...
BIMI Medical(BIMI) - 2022 Q4 - Annual Report
2023-05-03 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended: December 31, 2022 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from __________ to __________ Commission File Number 000-50155 BIMI International Medical Inc. (Exact Name of Registrant as Specified in Its Charter) | --- | --- | --- | --- | |- ...